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Rational Use of Medicines 
There is ample evidence to support the observation that 
medicines are generally not used rationally or appro-
priately. The World Health Organisation (WHO) indi-
cates that “Rational use of medicines requires that "pa-
tients receive medications appropriate to their clinical 
needs, in doses that meet their own individual require-
ments, for an adequate period of time, and at the lowest 
cost to them and their community" 
(http://www.who.int/medicines/areas/rational_use/en/) 
 
The problem of inappropriate or irrational use of medi-
cines occurs in all countries; and in various dimen-
sions.  Examples of irrational use of medicines include: 
poly-pharmacy (use of too many medicines per pa-
tient), inappropriate use of antimicrobials, inappropri-
ate use of injections; failure to prescribe according to 
clinical guidelines and inappropriate self-medication.  
 
This global problem has adverse consequences on cost 
of care to patients and the health system, emergence of 
antimicrobial resistance (in the case of antibiotics and 
antimicrobial agents), increased risk of adverse drug 
reactions and reduced confidence in the healthcare de-
livery system by patients. The practice may also in-
volve overuse or underuse of medicines. 
 
Standard treatment guidelines have become a tool for 
addressing, in part, the problem of irrational use of 
medicines. The evidence for choice of therapy in many 
developing countries is based on studies done outside 
their geographic regions. There is an urgent need for 
clinicians, scientists and governments to undertake or 
support local studies to provide evidence to support 
clinical guidelines. 
 
In this issue of the journal Eslami et al (page 185) 
compare intramuscular Benzathine penicillin G and 
orally administered Amoxicillin in the treatment of 
Group A streptococcal pharyngitis. The study observed 
that the two medicines were equal in reducing the man-
ifestations of pharyngitis but Penicillin G was better at 
reducing exudates. Treatment failure was higher in the 
amoxicillin group (16.9%) than the Penicillin G group 
(6.4%). This information may be useful in making lo-
cal decisions on the choice of treatment for Group A 
streptococcal pharyngitis. 
 
Adverse drug reaction reporting 
The reporting of adverse drug reactions is poorly done 
in many health systems. Spontaneous reporting is very 
common but not effective in most cases. In a report on 
a survey on adverse drug reaction reporting in Ghana 
(page 189) about 27.4% of the respondents had re-
ceived training in ADR. Reporting of ADR was poor; 
half of the respondents have noted an ADR but only 
20% had reported them. Clinicians working at public 
health facilities were more likely to report an ADR. 
Absence of reporting forms was a prominent reason for 
not reporting. Adverse drug reaction reporting is an 
essential mechanism for determining the clinical use-
fulness of a medication; contributes to decisions in 
keeping medicines in circulation and also preventing 
unnecessary death or disability from medicines. 
 
Adherence to treatment 
The management of HIV/AIDS is assisted by many 
protocols and guidelines. These cover various areas 
including prescribing of ante-retroviral medicines, ad-
herence on the part of prescriber as well as the patient. 
Indeed, the health system itself also has the responsibil-
ity to adhere to providing the recommended therapeutic 
agents. Adherence to treatment is an important aspect 
of HIV/AIDS management. There is paucity of infor-
mation on ADRs in patients receiving HAART. In this 
issue of the journal we publish a paper (page 194) that 
shows that adherence to treatment in HIV/AIDS is a 
associated good therapeutic response. However, the 
study found 23 different ARV-drug combinations in a 
single clinic that were not along the national guide-
lines.  
 
It is clear that after more than two decades of advocat-
ing for the rational use of medicines, the investment by 
many countries, agencies and health professional asso-
ciations in producing clinical protocols and guidelines; 
and instituting training programmes to promote their 
use, these measures on their own do not appear to have 
resulted in a significant improvement in how medicines 
are used in an efficient and quality manner.  
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